Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth

Sangodkar, J; Perl, A; Tohme, R; Kiselar, J; Kastrinsky, DB; Zaware, N; Izadmehr, S; Sangodkar, J; Perl, A; Tohme, R; Kiselar, J; Kastrinsky, DB; Zaware, N; Izadmehr, S; Mazhar, S; Wiredja, DD; O'Connor, CM; Hoon, D; Dhawan, NS; Schlatzer, D; Yao, S; Leonard, D; Borczuk, AC; Gokulrangan, G; Wang, L; Svenson, E; Farrington, CC; Yuan, E; Avelar, RA; Stachnik, A; Smith, B; Gidwani, V; Giannini, HM; McQuaid, D; McClinch, K; Wang, Z; Levine, AC; Sears, RC; Chen, EY; Duan, Q; Datt, M; Haider, S; Ma'ayan, A; DiFeo, A; Sharma, N; Galsky, MD; Brautigan, DL; Ioannou, YA; Xu, W; Chance, MR; Ohlmeyer, M; Narla, G; - view fewer (2017) Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth. Journal of Clinical Investigation 10.1172/JCI89548 . (In press). Green open access

http://ift.tt/2qQwt0D